BNET Industries

Diamond Drugs Inc.

is in the Retail Industry

Last Fiscal Year Sales:$121.7M

Private
US

Dow Jones Description

Provider of Pharmaceutical Services to Prisons

President & CEO

Number of Employees 480

Contact Information

645 Kolter Dr

Indiana, Pennsylvania 15701-3570

www.diamondphar...

(724) 349-1111

Peer Companies

NAICS Code Pharmacies and Drug Stores: 446110

Executive Profiles

Decision Makers

Name (plus bio)	Position
Joan Zilner	President & CEO
Gilbert Zilner	Vice President
Mark Zilner	Director, Operations
Louann Bowser	Controller

Organization	Position	Status
Diamond Drugs, Inc.	President & CEO	Current

Organization	Position	Status
Diamond Drugs, Inc.	Vice President	Current

Organization	Position	Status
Diamond Drugs, Inc.	Director, Operations	Current

Organization	Position	Status
Diamond Drugs, Inc.	Controller	Current

Industry Transcripts by Seeking Alpha

AC Moore Arts & Crafts Inc. Q3 2009 Earnings Conference Call
on Nov 06, 2009about ACMR
Omnicare, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about OCR
MarineMax Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 05, 2009about HZO
K-Swiss Inc. Q3 2009 Earnings Call Transcript
on Nov 05, 2009about KSWS
CVS Caremark Q3 2009 Earnings Call Transcript
on Nov 05, 2009about CVS

Glass Door

Retail Industry Companies

Company	Employer Rating
Costco Wholesale	3.5
Target	3.2
Amazon.com	3.3
eBay	2.8
Wal-Mart	3.0

IndustryTop Rated

Whole Foods Twitters on the Cheap 4 votes
P&G Retail Push Makes Sense, Risks Aside 3 votes
Walmart Readies Smaller Stores for Smarter Growth 2 votes
Aeropostale Delivers New Store for Trendy Tweens 1 votes
Tiffany, Williams-Sonoma Rewarded for Poor Sales 1 votes

Your Work Five Ways to Speak Like Obama

Five Ways to Speak Like Obama

Barack Obama is a master at grabbing and keeping his audience's attention, which is the number one goal of any public speaker. How does he do it? Here are five key lessons from Obama's rhetorical playbook.
Your Industry Vanity Pharmas Win a Round Against J&J

Vanity Pharmas Win a Round Against J&J

Johnson & Johnson (JNJ) has stopped marketing wrinkle filler Evolence, a little more than a year after it was launched. Doctors were informed of the news on Nov. 3. Kudos to Allergan (AGN) and Medicis (MRX) , marketers of Juvederm and Restylane, respectively: The rivals have successfully seen off the much larger J&J, which bought its way into the category in 2008 for $1 billion.
Your Money 29 Fees We Hate Most

29 Fees We Hate Most

An increasing number of businesses, from hotels to cell phone providers, are advertising bargain prices and then tacking on hidden fees and charges to boost the final cost. Here’s how you can fight back.